Vitamin Shoppe Inc (NYSE:VSI) shares fell 5% during mid-day trading on Friday . The company traded as low as $8.93 and last traded at $9.08. 610,558 shares were traded during trading, a decline of 1% from the average session volume of 618,656 shares. The stock had previously closed at $9.56.
A number of research firms recently issued reports on VSI. ValuEngine upgraded Vitamin Shoppe from a “hold” rating to a “buy” rating in a research report on Wednesday, August 8th. Barclays lowered Vitamin Shoppe from an “equal weight” rating to an “underweight” rating in a research report on Friday, September 7th. Morgan Stanley began coverage on Vitamin Shoppe in a research report on Monday, September 17th. They set an “equal weight” rating and a $14.00 price objective for the company. Finally, Zacks Investment Research lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Wednesday.
The stock has a market cap of $242.69 million, a PE ratio of 23.28 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.96 and a quick ratio of 0.32.
In other Vitamin Shoppe news, Director Guillermo Marmol purchased 8,900 shares of Vitamin Shoppe stock in a transaction on Friday, August 10th. The stock was bought at an average price of $11.21 per share, for a total transaction of $99,769.00. Following the transaction, the director now owns 49,479 shares of the company’s stock, valued at approximately $554,659.59. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Sharon M. Leite purchased 5,500 shares of Vitamin Shoppe stock in a transaction on Friday, August 31st. The shares were acquired at an average price of $12.64 per share, with a total value of $69,520.00. Following the transaction, the chief executive officer now directly owns 5,500 shares in the company, valued at approximately $69,520. The disclosure for this purchase can be found here. Insiders own 18.50% of the company’s stock.
A number of hedge funds have recently made changes to their positions in VSI. Schwab Charles Investment Management Inc. boosted its position in Vitamin Shoppe by 29.4% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 863,237 shares of the specialty retailer’s stock worth $3,756,000 after acquiring an additional 196,125 shares during the period. California Public Employees Retirement System boosted its position in Vitamin Shoppe by 5.0% during the 1st quarter. California Public Employees Retirement System now owns 282,758 shares of the specialty retailer’s stock worth $1,230,000 after acquiring an additional 13,338 shares during the period. Dimensional Fund Advisors LP boosted its position in Vitamin Shoppe by 10.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock worth $7,288,000 after acquiring an additional 158,123 shares during the period. GSA Capital Partners LLP acquired a new position in Vitamin Shoppe during the 1st quarter worth $109,000. Finally, Millennium Management LLC acquired a new position in Vitamin Shoppe during the 1st quarter worth $1,628,000. Institutional investors own 89.53% of the company’s stock.
About Vitamin Shoppe (NYSE:VSI)
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.